PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-08-13

Date Title Company
13-Aug-2024 Phase 1b/2 "RAINIER" Frontline Acute Myeloid Leukemia (AML) Trial Initiated AccessWire
13-Aug-2024 Compassion Center Expresses Gratitude to Rebecca Siewert of N.W. Classic and Woodburn Property Management for Highlighting Housing Disparities in Oregon AccessWire
13-Aug-2024 Jaguar Health Reports Second Quarter 2024 Financial Results AccessWire
13-Aug-2024 Venistro Biotech Highlights Key Trends Shaping the PCD Pharma Franchise Market for 2025-2032 Venistro Biotech
13-Aug-2024 InnoScot Health calls on Scotland to embrace learnings to capitalise upon £80bn research, development and innovation programme InnoScot Health
13-Aug-2024 Vytalize Health Named Fastest-Growing Private Company in America by Inc. Magazine AccessWire
13-Aug-2024 Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners AccessWire
13-Aug-2024 What to Look for in a Trusted Itraconazole Capsules Manufacturer: Insights from Leading Pharma Manufacturer DM Pharma DM Pharma Private Limited
13-Aug-2024 Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study Eckert & Ziegler SE
13-Aug-2024 DEFENCE THERAPEUTICS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER ADVANCES Defence Therapeutics Inc.
13-Aug-2024 Evotec Announces Strong Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb AccessWire
13-Aug-2024 Medios AG continues its growth trajectory in the first half of 2024 and records disproportionately high increase in earnings Medios AG
13-Aug-2024 Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb Evotec SE
13-Aug-2024 Solid progress in H1 2024 – Upgrade of 2024 full-year guidance – Mid-term target to double 2023 revenue by 2028 PolyPeptide Group
13-Aug-2024 Formycon reports a strong first half-year with multiple milestones achieved Formycon AG